Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • AC Immune amends IPO

    AC Immune S.A., Lausanne, Switzerland Business: Neurology Date announced: 2016-09-13 Type: IPO To be raised: Up to $59.1 million Shares: 4.5 million Price: $11-$13 Underwriters: Credit Suisse; Jefferies; Leerink …

    Published on 9/19/2016
  • AmpliPhi BioSciences amends follow-on

    AmpliPhi Biosciences Corp. (NYSE-M:APHB), Richmond, Va. Business: Infectious Date announced: 2016-09-14 Type: Follow-on To be raised: Up to $10 million Shares: 4.8 million Price prior: $1.70 Underwriters: Roth Capital …

    Published on 9/19/2016
  • Acelity completes venture financing

    Acelity L.P. Inc., San Antonio, Texas Business: Dermatology, Dental, Transplant Date completed: 2016-09-13 Type: Venture financing Raised: $1.8 billion Note: The financing comprises senior secured notes, which bear 9.…

    Published on 9/19/2016
  • Advantagene completes venture financing

    Advantagene Inc., Auburndale, Mass. Business: Cancer Date completed: 2016-09-12 Type: Venture financing Raised: $14.2 million

    Published on 9/19/2016
  • Aequus Pharmaceuticals completes private placement

    Aequus Pharmaceuticals Inc. (TSX-V:AQS; OTCQB:AQSZF), Vancouver, B.C. Business: Drug delivery, Neurology, Gastrointestinal Date completed: 2016-09-13 Type: Private placement Raised: C$2.7 million ($2.1 million) Shares: …

    Published on 9/19/2016
  • Aerie Pharmaceuticals completes follow-on

    Aerie Pharmaceuticals Inc. (NASDAQ:AERI), Bedminster, N.J. Business: Ophthalmic Date completed: 2016-09-16 Type: Follow-on Raised: $75 million Price: $29.50 Underwriter: Cantor Fitzgerald

    Published on 9/19/2016
  • Aerie Pharmaceuticals completes private placement

    Aerie Pharmaceuticals Inc. (NASDAQ:AERI), Bedminster, N.J. Business: Ophthalmic Date completed: 2016-09-16 Type: Private placement Raised: $50 million Shares: 1.5 million Shares after offering: 29.4 million Placement …

    Published on 9/19/2016
  • Agios completes follow-on

    Agios Pharmaceuticals Inc. (NASDAQ:AGIO), Cambridge, Mass. Business: Cancer, Endocrine/Metabolic Date completed: 2016-09-14 Type: Follow-on Raised: $150 million Shares: 3.4 million Price: $44.50 Shares after offering: …

    Published on 9/19/2016
  • Avitide completes venture financing

    Avitide Inc., Lebanon, N.H. Business: Biomanufacturing Date completed: 2016-09-12 Type: Venture financing Raised: Not disclosed Investor: Mithril Capital Management Note: The amount raised is not disclosed.

    Published on 9/19/2016
  • BrainVectis completes venture financing

    BrainVectis, Fontenay-aux-Roses, France Business: Neurology, Gene/Cell therapy Date completed: 2016-09-13 Type: Venture financing Raised: EUR1 million ($1.1 million) Investor: Private investors

    Published on 9/19/2016
  • Caladrius Biosciences completes direct public offering

    Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Business: Gene/Cell therapy, Cardiovascular, Endocrine/Metabolic Date completed: 2016-09-15 Type: Direct public offering Raised: $4 million Shares: 847,458 Price:…

    Published on 9/19/2016
  • Capricor Therapeutics completes follow-on

    Capricor Therapeutics Inc. (NASDAQ:CAPR), Beverly Hills, Calif. Business: Cardiovascular Date completed: 2016-09-16 Type: Follow-on Raised: $8.6 million Shares: 2.7 million Price: $3.20 Shares after offering: 21 million…

    Published on 9/19/2016
  • Capricor Therapeutics completes private placement

    Capricor Therapeutics Inc. (NASDAQ:CAPR), Beverly Hills, Calif. Business: Cardiovascular Date completed: 2016-09-16 Type: Private placement Raised: $1 million Shares: 312,500 Price: $3.20 Shares after offering: 21 …

    Published on 9/19/2016
  • Cerecor completes private placement

    Cerecor Inc. (NASDAQ:CERC), Baltimore, Md. Business: Neurology Date completed: 2016-09-12 Type: Private placement Raised: $1 million Shares: 250,000 Price: $4 Shares after offering: 8.9 million Investor: Aspire Capital …

    Published on 9/19/2016
  • CytoDyn completes direct public offering

    CytoDyn Inc. (OTCBB:CYDY), Vancouver, Wash. Business: Infectious, Transplant Date completed: 2016-09-12 Type: Direct public offering Raised: $10 million Shares: 13.3 million Price: $0.75 Shares after offering: 137.9 …

    Published on 9/19/2016
  • Delinia completes venture financing

    Delinia Inc., Cambridge, Mass. Business: Autoimmune Date completed: 2016-09-14 Type: Venture financing Raised: $35 million Investors: Sofinnova Partners; Atlas Venture

    Published on 9/19/2016
  • GammaDelta Therapeutics completes venture financing

    GammaDelta Therapeutics Ltd., London, U.K. Business: Cancer Date completed: 2016-09-15 Type: Venture financing Raised: Not disclosed Investors: Abingworth Management; Cancer Research Technology; Kings College London; …

    Published on 9/19/2016
  • Gilead completes private placement of senior notes

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Biopharmaceuticals, Infectious, Pulmonary Date completed: 2016-09-15 Type: Private placement of senior notes Raised: $5 billion Underwriters: Merrill …

    Published on 9/19/2016
  • Immune Design completes follow-on

    Immune Design Corp. (NASDAQ:IMDZ), Seattle, Wash. Business: Cancer, Infectious Date completed: 2016-09-15 Type: Follow-on Raised: $30 million Shares: 4.8 million Price: $6.25 Shares after offering: 25 million …

    Published on 9/19/2016
  • Inflazome completes venture financing

    Inflazome Ltd., Dublin, Ireland Business: Inflammation Date completed: 2016-09-12 Type: Venture financing Raised: EUR15 million ($16.9 million) Investors: Fountain Healthcare Partners; Novartis Venture Fund

    Published on 9/19/2016
  • Insulet completes private placement of senior convertible notes

    Insulet Corp. (NASDAQ:PODD), Billerica, Mass. Business: Drug delivery, Endocrine/Metabolic Date completed: 2016-09-07 Type: Private placement of senior convertible notes Raised: $300 million Shares outstanding prior: 57…

    Published on 9/19/2016
  • Intarcia completes venture financing

    Intarcia Therapeutics Inc., Boston, Mass. Business: Endocrine/Metabolic Date completed: 2016-09-15 Type: Venture financing Raised: $215 million Investors: Baillie Gifford; Pritzker Family; Lucion Venture Capital; …

    Published on 9/19/2016
  • Matinas BioPharma completes private placement of convertible preferred stock

    Matinas BioPharma Holdings Inc. (OTCQB:MTNB), Bedminster, N.J. Business: Infectious, Endocrine/Metabolic Date completed: 2016-09-12 Type: Private placement of convertible preferred stock Raised: $3.6 million Shares: 719…

    Published on 9/19/2016
  • Peloton Therapeutics completes venture financing

    Peloton Therapeutics Inc., Dallas, Texas Business: Cancer, Cardiovascular, Hematology Date completed: 2016-09-15 Type: Venture financing Raised: $52.4 million Investors: Foresite Capital Management; Remeditex Ventures; …

    Published on 9/19/2016
  • Promimic completes venture financing

    Promimic AB, Gothenburg, Sweden Business: Dental, Musculoskeletal Date completed: 2016-09-13 Type: Venture financing Raised: SEK23.8 million ($2.8 million) Investors: Chalmers Ventures; Karolinska Development AB; Almi …

    Published on 9/19/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993